非高密度脂蛋白胆固醇、TyG指数对急性 缺血性脑卒中后早期认知障碍的预测价值
The Predictive Value of Non-HDL-C and the TyG Index for Early Cognitive Impairment after Acute Ischemic Stroke
摘要: 目的:探讨非高密度脂蛋白胆固醇(non-High-Density Lipoprotein Cholesterol, non-HDL-C)与甘油三酯–葡萄糖指数(Triglyceride-Glucose Index, TyG)单独及联合对急性缺血性脑卒中(Acute Ischemic Stroke, AIS)后早期认知障碍的预测价值。方法:纳入100例AIS患者为研究对象。分为出现早期认知障碍组(50例)与认知正常组(50例)。检测空腹血糖(FPG)、糖化血红蛋白(HbA1C)、同型半胱氨酸(Hcy)、尿酸(UA)及总胆固醇(TC)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、甘油三酯(TG)水平,计算TyG指数及non-HDL-C;认知功能于AIS发病后第7日采用蒙特利尔认知评估量表(Montreal Cognitive Assessment, MoCA)进行评定,以总分 < 26分定义为认知障碍。所有患者于发病后3个月进行随访,再次进行认知评估,以最终评分 < 26分定义为PSCI。使用Logistic回归模型分析相关危险因素,并通过受试者工作特征(Receiver Operating Characteristic, ROC)曲线下面积评估各指标的诊断效能。结果:认知障碍组TyG指数(8.75 ± 0.48 vs. 8.34 ± 0.24)与non-HDL-C [3.17 (2.76, 3.52) vs. 2.94 (2.69, 3.21)]均高于对照组(P < 0.05)。多因素分析显示,二者均为AIS后认知障碍的独立危险因素(P < 0.05)。二者联合应用的预测效能其AUC为0.798 (95% CI: 0.704~0.892, P < 0.001),敏感度为72%,特异度为90%,优于单一指标。结论:较高的non-HDL-C与TyG指数可独立预测AIS后早期认知障碍风险,联合应用具有更好的预测价值。
Abstract: Objective: To evaluate the predictive value of non-High-Density Lipoprotein Cholesterol (non-HDL-C) and the Triglyceride-Glucose (TyG) index, both individually and in combination, for early cognitive impairment after Acute Ischemic Stroke (AIS). Methods: This study included 100 AIS patients. They were stratified into an early cognitive impairment group and a cognitively normal group (50 cases each). Fasting Plasma Glucose (FPG), glycated Hemoglobin (HbA1c), Homocysteine (Hcy), Uric Acid (UA), Total Cholesterol (TC), High-Density Lipoprotein Cholesterol (HDL-C), Low-Density Lipoprotein Cholesterol (LDL-C), and Triglycerides (TG) levels were measured. The TyG index and non-HDL-C were calculated. Cognitive function was evaluated on day 7 after AIS onset using the Montreal Cognitive Assessment (MoCA), with a score of <26 indicating impairment. All patients underwent follow-up cognitive assessment at 3 months post-onset, with a final score of <26 defining PSCI. Risk factors were analyzed via Logistic regression, and the predictive performance of relevant indicators was analyzed using the Area Under the Receiver operating characteristic curve (AUC). Results: The cognitive impairment group showed significantly higher TyG index (8.75 ± 0.48 vs. 8.34 ± 0.24) and non-HDL-C levels [3.17 (2.76, 3.52) vs. 2.94 (2.69, 3.21)] compared to the control group (P < 0.05). Multivariate analysis identified both as independent risk factors for early cognitive impairment after AIS (P < 0.05). Their combination yielded an AUC of 0.798 (95% CI: 0.704~0.892), with 72% sensitivity and 90% specificity, outperforming either marker alone. Conclusion: Elevated non-HDL-C and TyG index levels are independently associated with an increased risk of early cognitive impairment after AIS. Their combined use offers superior predictive value.
文章引用:徐靖雯, 祝善尧. 非高密度脂蛋白胆固醇、TyG指数对急性 缺血性脑卒中后早期认知障碍的预测价值[J]. 临床医学进展, 2026, 16(2): 2938-2946. https://doi.org/10.12677/acm.2026.162704

参考文献

[1] Qureshi, D., Topiwala, A., Al Abid, S.U., Allen, N.E., Kuźma, E. and Littlejohns, T.J. (2024) Association of Metabolic Syndrome with Neuroimaging and Cognitive Outcomes in the UK Biobank. Diabetes Care, 47, 1415-1423. [Google Scholar] [CrossRef] [PubMed]
[2] Yang, Y., Peng, P., Huang, H., Zhao, Y., Li, Y., Xu, X., et al. (2024) The Triglyceride-Glucose Index and Risk of Cognitive Impairment: A Systematic Review and Meta-Analysis with Inclusion of Two National Databases. Frontiers in Neurology, 15, Article 1496871. [Google Scholar] [CrossRef] [PubMed]
[3] Li, L., Zhuang, L., Xu, Z., Jiang, L., Zhai, Y., Liu, D., et al. (2024) U-Shaped Relationship between Non-High-Density Lipoprotein Cholesterol and Cognitive Impairment in Chinese Middle-Aged and Elderly: A Cross-Sectional Study. BMC Public Health, 24, Article No. 1624. [Google Scholar] [CrossRef] [PubMed]
[4] Tian, N., Song, L., Hou, T., Fa, W., Dong, Y., Liu, R., et al. (2024) Association of Triglyceride-Glucose Index with Cognitive Function and Brain Atrophy: A Population-Based Study. The American Journal of Geriatric Psychiatry, 32, 151-162. [Google Scholar] [CrossRef] [PubMed]
[5] Bai, W., An, S., Jia, H., Xu, J. and Qin, L. (2024) Relationship between Triglyceride-Glucose Index and Cognitive Function among Community-Dwelling Older Adults: A Population-Based Cohort Study. Frontiers in Endocrinology, 15, Article 1398235. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, J., Tang, H., Tian, J., Xie, Y. and Wu, Y. (2024) Non-Insulin-Based Insulin Resistance Indices Predict Early Neurological Deterioration in Elderly and Middle-Aged Acute Ischemic Stroke Patients in Northeast China. Scientific Reports, 14, Article No. 16138. [Google Scholar] [CrossRef] [PubMed]
[7] Di Nisio, M., Prisciandaro, M., Rutjes, A.W., Russi, I., Maiorini, L. and Porreca, E. (2014) Dementia in Patients with Atrial Fibrillation and the Value of the Hachinski Ischemic Score. Geriatrics & Gerontology International, 15, 770-777. [Google Scholar] [CrossRef] [PubMed]
[8] Berko, A., Bar-Sella, A., Fisher, H., Sobolev, M., Pollak, J.P. and Zilcha-Mano, S. (2022) Development and Evaluation of the HRSD-D, an Image-Based Digital Measure of the Hamilton Rating Scale for Depression. Scientific Reports, 12, Article No. 14342. [Google Scholar] [CrossRef] [PubMed]
[9] Pei, C., He, C., Li, H., Li, X., Huang, W., Liu, J., et al. (2024) Clinical and Imaging Markers for the Prognosis of Acute Ischemic Stroke. Frontiers in Neurology, 15, Article 1345914. [Google Scholar] [CrossRef] [PubMed]
[10] Islam, N., Hashem, R., Gad, M., Brown, A., Levis, B., Renoux, C., et al. (2023) Accuracy of the Montreal Cognitive Assessment Tool for Detecting Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Alzheimers & Dementia, 19, 3235-3243. [Google Scholar] [CrossRef] [PubMed]
[11] 汤爱洁, 戴秀娟, 胡鑫淼, 等. 缺血性脑卒中后3-6个月认知障碍影响因素的Meta分析[J]. 中国全科医学, 2022, 25(24): 3049-3056+3064.
[12] 蒯晓洋, 沈伟, 张薇薇, 等. 三酰甘油-葡萄糖指数及其衍生指数与胰岛素抵抗的相关性研究[J]. 中国临床保健杂志, 2024, 27(6): 754-759.
[13] Tang, Y., Li, L. and Li, J. (2024) Correlations of the Triglyceride-Glucose Index and Modified Indices with Arterial Stiffness in Overweight or Obese Adults. Frontiers in Endocrinology, 15, Article 1499120. [Google Scholar] [CrossRef] [PubMed]
[14] El-Sehrawy, A.A.M.A., Khachatryan, L.G., Kubaev, A., Rekha, M.M., Rab, S.O., Kaur, M., et al. (2025) Triglyceride-Glucose Index: A Potent Predictor of Metabolic Risk Factors and Eating Behavior Patterns among Obese Individuals. BMC Endocrine Disorders, 25, Article No. 71. [Google Scholar] [CrossRef] [PubMed]
[15] 李春贤, 刘安诺. 成年人肥胖和脂质相关指标对代谢综合征的影响及预测价值研究[J]. 中国全科医学, 2025, 28(21): 2595-2603+2610.
[16] Han, Y., Meng, X. and Wang, D. (2024) Association between Triglyceride Glucose Index with Cognitive Impairment and Dementia in Adult Population: A Meta-analysis. Hormone and Metabolic Research, 56, 737-748. [Google Scholar] [CrossRef] [PubMed]
[17] Sun, M., Liu, M., Li, Q., Liu, S., Yang, H., Song, Y., et al. (2024) Insulin Attenuates LPS-Induced Cognitive Impairment and Ferroptosis through Regulation of Glucose Metabolism in Hippocampus. CNS Neuroscience & Therapeutics, 30, e14887. [Google Scholar] [CrossRef] [PubMed]
[18] Song, D., Li, Y., Yang, L., Luo, Y. and Yao, X. (2025) Bridging Systemic Metabolic Dysfunction and Alzheimer’s Disease: The Liver Interface. Molecular Neurodegeneration, 20, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[19] van Zwol, W., van de Sluis, B., Ginsberg, H.N. and Kuivenhoven, J.A. (2024) VLDL Biogenesis and Secretion: It Takes a Village. Circulation Research, 134, 226-244. [Google Scholar] [CrossRef] [PubMed]
[20] Abuelezz, S.A. and Hendawy, N. (2021) HMGB1/RAGE/TLR4 Axis and Glutamate as Novel Targets for PCSK9 Inhibitor in High Fat Cholesterol Diet Induced Cognitive Impairment and Amyloidosis. Life Sciences, 273, Article ID: 119310. [Google Scholar] [CrossRef] [PubMed]
[21] 庄中胜, 曹晓涵. 血清Lp-PLA2、ox-LDL水平变化与急性心肌梗死患者病情相关性及对预后的评估价值[J]. 中国卫生工程学, 2024, 23(2): 262-264+267.
[22] Li, H., Ke, X., Feng, B., Tian, H., Cai, Z., Zhang, A., et al. (2025) Research Progress on the Mechanism and Markers of Metabolic Disorders in the Occurrence and Development of Cognitive Dysfunction after Ischemic Stroke. Frontiers in Endocrinology, 16, Article 1500650. [Google Scholar] [CrossRef] [PubMed]